Table 4.
Sensitivity analyses of the impact of each trial on pooled effect size
| Study omitted | WMD (95 % CI) |
|---|---|
| Ochiai et al (2010) | -4.41 (-8.54, -0.28) |
| Wong et al (2012) | -3.66 (-7.85, 0.51) |
| Figueroa et al (2009) | -5.42 (-8.78, -2.07) |
| Figueroa et al (2009) | -3.71 (-7.85, 0.43) |
| Wong et al (2015) | -4.58 (-8.62, -0.55) |
| Gonzales et al (2017) | -4.41 (-8.46 , -0.36) |
| Gonzales et al (2017) | -4.45 (-8.52 , -0.38) |
| Figueroa et al (2016) | -4.045 (-8.51, 0.42) |
| Sanchez-Gonzalez et al (2012) | -3.08 (-6.71, 0.54) |
| Munoz et al (2012) | -3.24 (-7.36, 0.86) |
| Ochiai et al (2010) | -2.52 (-4.80, -0.24) |
| Wong et al (2012) | -1.75 (-4.10, 0.58) |
| Figueroa et al (2009) | -2.50 (-4.85, -0.14) |
| Figueroa et al (2009) | -2.08 (-4.54, 0.37) |
| Wong et al (2015) | -2.42 (-4.80, -.045) |
| Gonzales et al (2017) | -2.30 (-4.74, 0.13) |
| Gonzales et al (2017) | -2.00 (-4.42, 0.41) |
| Figueroa et al (2016) | -1.35 (-3.41, 0.71) |
| Sanchez-Gonzalez et al (2012) | -1.50 (-3.69, 0.67) |
| Munoz et al (2012) | -2.20 (-4.76, 0.35) |